SCHEMBL20370720

SCHEMBL20370720

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4ccc5nc6c(nc5c4)Sc4ccccc4S6)c3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 2/20 0.38
▸ PIK3R1 P27986 1/20 0.38
▸ KMT2A Q03164 6/20 0.38
▸ MEN1 O00255 5/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ HPGD P15428 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ LMNA P02545 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ NTSR1 P30989 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PI4KA P42356 1/20 0.35
▸ PI4KB Q9UBF8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20370741 0.88 MEN1 (0.38) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20370680 0.82 MEN1 (0.40) PIK3CAPIK3R1KMT2AMEN1ALDH1A1
SCHEMBL20370705 0.81 L3MBTL1 (0.37) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL27288543 0.80 MEN1 (0.43) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20370753 0.79 ADORA2A (0.33) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL20370728 0.78 PIK3CA (0.38) PIK3CAPIK3R1KMT2AMEN1KDM4E
SCHEMBL17932798 0.77 L3MBTL1 (0.47) PIK3CAPIK3R1KMT2AMEN1ALDH1A1
SCHEMBL19762120 0.75 MEN1 (0.55) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL17720920 0.75 MEN1 (0.55) KMT2AMEN1ALDH1A1HPGDMAPT
SCHEMBL15458334 0.75 MEN1 (0.55) KMT2AMEN1ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-01 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10854823-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CRY2, CYP1A1 PIK3CA 4290/4885PIK3R1 4847/4885KMT2A 992/4885
US-20180198074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CYP1A1 PIK3CA 4290/4885PIK3R1 4847/4885KMT2A 992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback